Stay updated with breaking news from Hematology Fellowship Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After receiving diversity, equity, and inclusion (DEI) training, fellows at Yale's medical school say they felt more comfortable dealing with racial inequality and sexual harassment.
Thomas Duffy, MD, professor emeritus of medicine (hematology) at Yale School of Medicine and Yale Cancer Center, served as director of the Hematology Fellowship
Study reveals blood tests can offer early indicator of severe COVID-19 ANI | Updated: Mar 02, 2021 09:44 IST Washington [US], March 2 (ANI): A recent study has found that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19patients. The findings of the study were published in the journal 'Blood Advances'. When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and ...
Read Time: When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. "Patients with high levels of these markers were much more like to require care...
E-Mail When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. New Yale research could help them identify important early clues. In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients. The findings appear in the Feb. 26 edition of Blood Advances. "Patients with hi...